AKT1 and type 2 diabetes mellitus: Our data presented here was the first to show the effectiveness of TBHQ on improving liver steatosis in T2DM and the mechanism of the anti-insulin resistance and anti-apoptosis effects of TBHQ related to the β-arrestin-2/PI3K/AKT pathway.